Solubilization of aggregation-prone heterologous proteins by covalent fusion of stress-responsive Escherichia coli protein, SlyD

被引:38
作者
Han, Kyung-Yeon [1 ]
Song, Jong-Am [1 ]
Ahn, Keum-Young [1 ]
Park, Jin-Seung [1 ]
Seo, Hyuk-Seong [1 ]
Lee, Jeewon [1 ]
机构
[1] Korea Univ, Dept Chem & Biol Engn, Sungbuk Ku, Seoul 136713, South Korea
关键词
Escherichia coli BL21( DE3); proteome; SlyD; solubility enhancer; stress response;
D O I
10.1093/protein/gzm055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proteome profile of Escherichia coli BL21(DE3) generated in response to heat shock stress was analyzed by two-dimensional electrophoresis (2-DE), wherein we identified a FKBP-type peptidyl-prolyl cis-trans isomerse (PPIases), SlyD, as a stress-responsive (i.e. aggregation-resistant) protein. Even under an imposed severe stress condition where 29 out of 858 soluble proteins were totally eliminated and the synthesis levels of 171 proteins decreased over 5-fold, a 3.37-fold increase induced by heat shock treatment was observed in the synthesis level of SlyD compared with a non-stress condition. As a fusion partner, as well as solubility enhancer, SlyD facilitated folding and significantly increased the solubility of many aggregation-prone heterologous proteins in E. coli cytoplasm. SlyD was very effective in sequestering interactive surfaces of heterologous proteins associated with non-specific protein-protein interactions and the formation of inclusion bodies, most likely as a result of intrinsic folding efficiencies and/or chaperone-like activities. SlyD was also shown to be suitable for the production of a biologically active fusion mutant of Pseudomonas putida cutinase that is of considerable biotechnological and commercial interest.
引用
收藏
页码:543 / 549
页数:7
相关论文
共 35 条
[1]  
Bae CS, 1998, BIOTECHNOL BIOENG, V57, P600, DOI 10.1002/(SICI)1097-0290(19980305)57:5<600::AID-BIT12>3.0.CO
[2]  
2-F
[3]   Recombinant protein folding and misfolding in Escherichia coli [J].
Baneyx, F ;
Mujacic, M .
NATURE BIOTECHNOLOGY, 2004, 22 (11) :1399-1408
[4]  
Carvalho CML, 1999, BIOTECHNOL BIOENG, V66, P17, DOI [10.1002/(SICI)1097-0290(1999)66:1<17::AID-BIT2>3.0.CO
[5]  
2-F, 10.1002/(SICI)1097-0290(1999)66:1&lt
[6]  
17::AID-BIT2&gt
[7]  
3.0.CO
[8]  
2-F]
[9]  
Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157
[10]  
Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO